Monday , April 12 2021

maxi donation for study



Together in the fight against the dog. Forward All and Aucc join forces to support research. The protocol of the American Ginseng study to prevent moderate fatigue in breast cancer patients who are active and subjected to adjuvant chemotherapy is funded by Azienda Ospedaliera di Perugia, Umbra Association for Combating Cancer and Association Avanti Avanti.

The study, which includes more than 15 Italian Cancer Centers, coordinates the complex structure of medical oncology at Perugia Hospital. The proponents are Dr. Fausto Roila and Dr. Sonia Fatigoni, Dr. Guglielmo Fumi, Dr. Alessandra Fabi and Dr. Enzo Ballatori.

Fatigue Tiredness (CRF) is defined as a subjective, stressful, persistent tiredness or exhaustion associated with cancer or its treatment, which is not proportional to the activity performed and hampers normal activities. The important feature of CRF is that it often does not ease sleep or rest. Among the various symptoms reported by the patient's neoplastic fatigue is what is considered the most difficult because it has a strongly negative impact on its quality of life. Also, the time of CRF production is extremely variable: in fact, it may appear before, during and even after a long time of ending anticancer therapy. The frequency of symptoms is high after the end of the therapy (from 20% to about 50%). American ginseng significantly improves fatigue-induced fatigue, but additional studies are needed to better understand its role in fatigue control and maximizing positive effects. The purpose of this morning's study is to confirm the effectiveness of American ginseng in preventing or reducing moderate to severe fatigue intensity in a homogeneous population of women who underwent preoperative chemotherapy after breast surgery. Total 290 patients will be involved. The study will last 18 months.

"The treatment that is being administered to date only treats the tiredness of fatigue. The great innovation of this protocol in the research lies in the desire to prevent the onset of symptoms – explains Dr. Fausto Roil, chief medical officer of the Medical Oncology Department. Ospedalieera from Perugia -. We are in the initial stage and expect to receive results within a year and a half. "

The total cost of research: forty thousand euros, fifteen thousand people donated the Umbrian Association for Combating Cancer, fifteen thousand from the Avanti Tutta association, and fifteen thousand were funded by Azienda Ospedaliera di Perugia. One of the main costs of such a protocol lies in the monitoring and methodology of the project that determines its quality and accuracy of the documentation of the results. The study methodology was appreciated by Professor Maurizio Tonato, who stressed the need for synergy between the institutions and the third sector.

Giuseppe Caforio, the president of AUCC, said "Today, we are convinced that there is no other way for synergies between associations and institutions, as well as the old design of Professor Maurice Tonato in the oncology network in teamwork between health care institutions today, to start thinking about the federation of associations that are dealing with oncology. The common goal is to achieve very little, each with its own characteristics. "

Leonardo Cenci, president of the association Avanti Tutta places emphasis on improving the quality of life that a research project can bring. "A cancer is a disease that is not just a patient but also a family." Scientific studies that improve the quality of life and the fatigue problem are important. If a person feels better he has a desire, so there is a sense of optimism and strength needed for everyday life as if it were the best ".

Dr. Emilio Duca, Director of Hospital Perugia, thanked the world of volunteering. "As Professor Tonato has pointed out, it is essential to invest in research and ensure independence, while the EU countries spend 2.03 percent of GDP on research, while in Italy we are 1.33 percent, and we still have a lot of work. I want to do is refer to the working methodology of oncology in Umbria. In our region, we are increasingly working in an interprofessional and interdisciplinary sense, guaranteeing analysis and a wide range of work and hence a complete clinical picture of the patient. "


Source link